Vedolizumab use in patients with inflammatory bowel diseases undergoing surgery: clinical trials and post-marketing experience

BACKGROUND: Patients with inflammatory bowel diseases frequently require surgery, but immunotherapies used in disease management may increase the risk of post-operative complications. We investigated frequencies of post-operative complications in patients who received vedolizumab—a gut-selective ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Bo, Blake, Aimee, Lasch, Karen, Smyth, Michael, Bhayat, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821312/
https://www.ncbi.nlm.nih.gov/pubmed/31687151
http://dx.doi.org/10.1093/gastro/goz034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821312/
https://www.ncbi.nlm.nih.gov/pubmed/31687151
http://dx.doi.org/10.1093/gastro/goz034

Ejemplares similares